Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Aging with a disability and state vocational rehabilitation services.
Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4(+)CD25(hi) T Cells of Type 1 Diabetic and Multiple Sclerosis Patients.
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder.
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
The protein arginine deiminases: Structure, function, inhibition, and disease.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
Optic neuritis: From magnocellular to cognitive residual dysfunction.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
Alemtuzumab in the treatment of multiple sclerosis.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
Combined central and peripheral demyelination: A case description.
The Scandinavian paradox revisited: Editorial comment on Berg-Hansen et al. 'High prevalence and no latitude gradient of multiple sclerosis in Norway'.

Pages